Related Experiment Videos
[Malignant lymphoma of the testicles].
La Revue De Medecine Interne
|September 1, 1992
Summary
Testicular non-Hodgkin's lymphoma (NHL) is a rare, aggressive cancer predominantly affecting older men. Intensive polychemotherapy has significantly improved outcomes, offering hope for complete remission.
Area of Science:
- Oncology
- Hematology
- Pathology
Context:
- Non-Hodgkin's lymphoma (NHL) can manifest in the testis, a rare occurrence.
- This condition predominantly affects elderly men and often presents with advanced disease.
- Histological subtypes include lymphoblastic, immunoblastic, and large cell diffuse lymphomas.
Purpose:
- To analyze the clinical characteristics, treatment, and outcomes of testicular non-Hodgkin's lymphoma (NHL).
- To evaluate the efficacy of intensive polychemotherapy in managing this rare malignancy.
Summary:
- A retrospective analysis of 12 patients with testicular NHL between 1980 and 1990.
- Most patients were over 50, with advanced disease (Ann Arbor stage IV in 8 cases).
- Intensive polychemotherapy led to complete remission in 4 patients, with a median survival of 30 months.
Impact:
- Testicular NHL is confirmed as a rare, high-grade malignancy primarily affecting older men.
- Advanced prognostic factors are common at diagnosis.
- Intensive polychemotherapy offers a transformative approach to managing testicular NHL, improving patient outcomes.